Abstract:Background: Precise and dynamic blood glucose regulation is paramount for both diagnosing and managing diabetes. Continuous glucose monitoring (CGM) coupled with insulin pumps forms an artificial pancreas, enabling closed-loop control of blood glucose levels. Indeed, this integration necessitates advanced micro-nano fabrication techniques to miniaturize and combine sensing and delivery modules on a single electrode. While microneedle technology can mitigate discomfort, concerns remain regarding infection risk and potential sensitivity limitations due to their short needle length. Methods: This study presents the development of an integrated electronic/fluidic microneedle patch (IEFMN) designed for both glucose sensing and insulin delivery. The use of minimally invasive microneedles mitigates nerve contact and reduces infection risks. The incorporation of wired enzymes addresses the issue of "oxygen deprivation" during glucose detection by decreasing the reliance on oxygen. The glucose-sensing electrodes employ wired enzyme functionalization to achieve lower operating voltages and enhanced resilience to sensor interference. The hollow microneedles' inner channel facilitates precise drug delivery for blood glucose regulation. Results: Our IEFMN-based system demonstrated high sensitivity, selectivity, and a wide response range in glucose detection at relatively low voltages. This effectively reduced interference from both external and internal active substances. The microneedle array ensured painless and minimally invasive skin penetration, while wired enzyme functionalization not only lowered sensing potential but also improved glucose detection accuracy. In vivo, experiments conducted in rats showed that the device could track subcutaneous glucose fluctuations in real-time and deliver insulin to regulate blood glucose levels. Conclusions: Our work suggests that the IEFMN-based system, developed for glucose sensing and insulin delivery, exhibits good performance during in vivo glucose detection and drug delivery. It holds the potential to contribute to real-time, intelligent, and controllable diabetes management.

Biomimetic Cell Membrane Layers for the Detection of Insulin and Glucagon

Integrated Olfaction, Gustation and Toxicity Detection by a Versatile Bioengineered Cell-Based Biomimetic Sensor

Multi-parameter Biosensor for Diabetes Monitoring

Multifunctional SH-SY5Y-based Biomimetic Sensor for Integrated Detection of Olfaction, Gustation and Toxicity

Top-down strategy of implantable biosensor using adaptable, porous hollow fibrous membrane.

Capturing Intercellular Sugar-Mediated Ligand-Receptor Recognitions Via a Simple Yet Highly Biospecific Interfacial System

Dynamic Monitoring of Β-Cell Injury with Impedance and Rescue by Glucagon-Like Peptide-1

Simultaneous and Rapid Detection of Glucose and Insulin: Coupling Enzymatic and Aptamer-Based Assays

Multiresponsive Supramolecular Theranostic Nanoplatform Based on Pillar[5]arene and Diphenylboronic Acid Derivatives for Integrated Glucose Sensing and Insulin Delivery

Enzyme Nanocapsules for Glucose Sensing and Insulin Delivery

Recent advances in cell membrane camouflage-based biosensing application

The application of a novel biomimetic enzyme p-BEs cascade catalytic platform for the rapid detection of glucose

A bio-inspired injectable hydrogel as a cell platform for real-time glycaemic regulation.

Glp-1 Receptor Mediated Targeting of A Fluorescent Zn2+ Sensor to Beta Cell Surface for Imaging Insulin/Zn2+ Release

Electroactive Molecularly Imprinted Polymer Nanoparticles (eMIPs) for Label-free Detection of Glucose: Toward Wearable Monitoring

A sandwich-type electrochemiluminescence aptasensor for insulin detection based on the nano-C60/BSA@luminol nanocomposite and ferrocene derivative

SERS-Based Aptamer Sensing Strategy for Diabetes Biomarker Detection

Integrated electronic/fluidic microneedle system for glucose sensing and insulin delivery

Label-free detection of insulin and glucagon within human islets of Langerhans using Raman spectroscopy

Genetically Encoded Synthetic Beta Cells for Insulin Biosynthesis and Release under Hyperglycemic Conditions

Flexible SERS Biosensor Based on Core-Shell Nanotags for Sensitive and Multiple Detection of T1DM Biomarkers